Maso Capital Partners Ltd

13F Portfolio Filings

Most recent 13F
Q4 2023
Location
Hong Kong
CIK
0001698093
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q4 2023 27 115,713 NOTE, HOLI, YY, SOHU 13F-HR 2/14/2024 000169809324000001
Q3 2023 37 183,560 NOTE, CD, HOLI, YY 13F-HR 11/13/2023 000169809323000004
Q2 2023 37 228,000 NOTE, CD, HOLI, SIMO 13F-HR 8/14/2023 000169809323000003
Q1 2023 36 150,581 NOTE, SOHU, YY, BILIBILI INC 13F-HR 5/11/2023 000169809323000002
Q4 2022 42 275,980 NOTE, FISCALNOTE HOLDINGS INC, YY, SOHU 13F-HR 2/13/2023 000169809323000001
Q3 2022 2 167,883 NOTE, FISCALNOTE HOLDINGS INC NEW HOLDINGS 11/15/2022 000169809322000006
Q3 2022 56 231,560 NOTE, YY, SOHU, JOYY INC 13F-HR 11/14/2022 000169809322000004
Q3 2022 2 29,337 NOTE, FISCALNOTE HOLDINGS INC NEW HOLDINGS 11/14/2022 000169809322000005
Q2 2022 61 177,206 DSAC, COHR, YY, SOHU 13F-HR 8/15/2022 000169809322000003
Q1 2022 56 245,872 JOBS, DSAC, NEW FRONTIER HEALTH CORP, YY 13F-HR 5/16/2022 000169809322000002
Q4 2021 47 217,642 DSAC, NEW FRONTIER HEALTH CORP, JOBS, YY 13F-HR 2/14/2022 000169809322000001
Q3 2021 41 221,973 JOBS, DSAC, NEW FRONTIER HEALTH CORP, YY 13F-HR 11/15/2021 000169809321000004
Q2 2021 54 304,431 JOBS, New Frontier Health Corp, DSAC, YY 13F-HR 8/16/2021 000169809321000003
Q1 2021 47 259,515 CHINA BIOLOGIC PRODUCTS INC, DSAC, New Frontier Health Corp, GNW 13F-HR 5/17/2021 000169809321000002
Q4 2020 45 366,585 SINA, CHINA BIOLOGIC PRODUCTS INC, DSAC, GNW 13F-HR 2/12/2021 000169809321000001
Q3 2020 21 178,899 CHINA BIOLOGIC PRODUCTS INC, GNW, ACIA, SINA 13F-HR 11/12/2020 000169809320000007
Q2 2020 22 247,871 CHINA BIOLOGIC PRODUCTS INC, BITA, WUBA, GNW 13F-HR 8/14/2020 000169809320000005
Q1 2020 21 386,086 AGN, CHINA BIOLOGIC PRODUCTS INC, BITA, CHANGYOU.COM LTD 13F-HR 5/11/2020 000169809320000004
Q4 2019 20 310,961 AGN, CHINA BIOLOGIC PRODS HLDGS INC, BITA, CHANGYOU COM LTD 13F-HR 2/12/2020 000169809320000003
Q3 2019 19 278,342 CELG, BPL, CHINA BIOLOGIC PRODS HLDGS I, BITA 13F-HR 11/14/2019 000169809319000007
Q2 2019 19 190,659 CELG, RHT, BPL, CHINA BIOLOGIC PRODS HLDGS I 13F-HR 8/13/2019 000169809319000006
Q1 2019 16 145,461 BMS, RHT, CELG, CHINA BIOLOGIC PRODS HLDGS I 13F-HR 5/14/2019 000169809319000004
Q4 2018 10 79,638 SPDR S&P 500 ETF TR calls, CHINA BIOLOGIC PRODS HLDGS I, GNW, YUMC 13F-HR 2/14/2019 000169809319000001
Q3 2018 12 102,682 SPDR S&P 500 ETF TR calls, BUNGE LIMITED calls, CHINA BIOLOGIC PRODS HLDGS I, YUMC 13F-HR 11/14/2018 000169809318000004
Q2 2018 24 176,286 KANG, BUNGE LIMITED calls, NXPI, NXP SEMICONDUCTORS N V calls 13F-HR 8/13/2018 000169809318000003
Q1 2018 18 115,195 KANG, NXPI, BUNGE LIMITED calls, BG 13F-HR 5/14/2018 000169809318000002
Q4 2017 14 82,313 KANG, NXPI, AXTA, CHANGYOU COM LTD 13F-HR 2/9/2018 000169809318000001
Q3 2017 17 138,272 POWERSHARES QQQ TRUST puts, POWERSHARES QQQ TRUST calls, KANG, NXPI 13F-HR 11/13/2017 000169809317000010
Q2 2017 10 75,488 ZPIN, KANG, NXPI, GENWORTH FINL INC puts 13F-HR 8/14/2017 000169809317000009
Q1 2017 7 49,772 KANG, MOMO INC calls, 0A2P.IL, IKANG HEALTHCARE GROUP INC calls 13F-HR 5/15/2017 000169809317000003
Q4 2016 5 29,826 KANG, 0A2P.IL, SINA, MOMO 13F-HR 2/14/2017 000169809317000002